Table 1.
Gene | Reported variant type |
Patient identifiers |
Clinical phenotype | Viral Infections | Reference |
---|---|---|---|---|---|
MCM4 | Homozygous c.70_71insG (frameshift) | 6 + 8 | Viral infection, short stature, adrenal insufficiency | P1: CMV P2: none P1: EBV, HSV, VZV P2: respiratory infections, EBV, HSV P3: EBV, HSV P4: respiratory infections, EBV, HSV, VZV P1: none P2: none P3: none P4: none P5: none P6: pneumonitis P7: none P8: none |
(8, 10) |
GINS1 | Compound heterozygous P1-2: c.−48C>G (new donor splice site) c.247C>T p.R83C (missense) P3: c.−60A>G (new donor splice site)P4: c.455G>A p.C152Y | 5 | Viral infection, intrauterine growth retardation, neutropenia | P1: CMV, chest infection P2: chest infection, rotavirus P3: CMV, VZV, adenovirus, RSV, rotavirus P4: VZV, HSV, chest infection P5: VZV, influenza |
(9) |
MCM10 | Compound heterozygous c.1276C>T p.R426C (missense) c.1744C>T p.R582X (stop gain) | 1 | Viral infections | CMV | (7) |
GINS4 | Compound heterozygous c.511G>C p.V171L (missense); c.C571T p.Q191X (stop gain) | 2 | Viral infections, intrauterine growth restriction and growth delay, neutropenia | P1: BCG infection after vaccination, CMV, VZV, HSV P2: VZV, HSV |
(6) |
POLA1 | Hypomorphic X-linked c.328G>A | 5 | XLPDR, viral infections, intrauterine and postnatal growth retardation, hypogonadism | Respiratory infections | (79) |
POLE2 | Homozygous splice-site SNP c.1Ex13G>T | 1 | Respiratory viruses, BCG and Candida albicans infections, diphtheria and tetanus toxoid, combined immunodeficiency, hypothyroidism, facial dysmorphism | BCG infection after vaccination, respiratory infections | (81) |
CMV: Cytomegalovirus
EBV: Epstein-Barr virus
HSV: Herpes simplex virus
VZV: Varicella zoster virus
RSV: respiratory syncytial virus
BCG: Bacillus Calmette-Guerin vaccine
SNP: single nucleotide polymorphism